Publications by authors named "Elisa Doni"
Article Synopsis
- Lymphoplasmacytic lymphoma (LPL) typically presents with an IgM paraprotein, but a study examined 45 rare non-IgM cases, revealing unique clinical features and differences from Waldenström's Macroglobulinemia (WM) patients.
- Non-IgM LPL had a higher percentage of females and more cases of lymphadenopathy and splenomegaly, while showing lower rates of serum monoclonal protein and bone marrow infiltration compared to WM.
- Both groups had similar five-year overall survival rates of 84%, though non-IgM LPL patients were more likely to be treated with anthracycline-based regimens.
A total of 318 consecutive myeloma patients underwent whole-body low-dose CT scan (WBLDCT) at baseline and during follow-up as a radiological assessment of lytic lesions in place of skeletal X-ray survey. After WBLDCT baseline assessment, 60% had bone involvement. The presence of lytic lesions represented the only met CRAB (hyperCalcaemia, Renal insufficiency, Anaemia, Bone lesions) criteria in 29% of patients.
View Article and Find Full Text PDFBackground: Diffuse large B-cell lymphoma is an aggressive lymphoma and a large number of studies have therefore focused on the search for prognostic factors. The same interest concerns FL, for which identification of patients candidates for watch and wait (W&W) strategy is still an option. Studies about the number and type of lymphocytes and monocytes detectable in patients with Hodgkin and non-Hodgkin lymphomas indicate they might affect the pathogenesis and prognosis of these diseases.
View Article and Find Full Text PDF